Roemmler, J., B. Steffin, B. Gutt, H. J. Schneider, C. Sievers, M. Bidlingmaier and J. Schopohl: The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment. In: Growth Hormone & IGF Research 20, 5, 338-344 (2010).
Roemmler, J., B. Steffin, B. Gutt, H. J. Schneider, C. Sievers, M. Bidlingmaier and J. Schopohl: The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment. In: Experimental and Clinical Endocrinology & Diabetes 117, 10, 664-664 (2009).
Roemmler, J., B. Steffin, B. Gutt, C. Sievers, M. Bidlingmaier and J. Schopohl: The effect of acute application of pegvisomant alone and in combination with octreotide on endogenous GH levels during a 6-h test in patients with acromegaly on constant pegvisomant treatment. In: Growth Hormone & IGF Research 19, 3, 245-251 (2009).
Roemmler, J., B. Steffin, B. Gutt, C. Sievers, M. Bidlingmaier and J. Schopohl: Acute effect of the growth hormone antagonist pegvisomant injection alone and in combination with a somatostatin analogue on endogenous GH and pegvisomant levels. In: Experimental and Clinical Endocrinology & Diabetes 115, 8, 553-553 (2007).
Gutt, B., B. Wowra, R. Alexandrov, E. Uhl, L. Schaaf, G. K. Stalla and J. Schopohl: Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly. In: Experimental and Clinical Endocrinology & Diabetes 113, 4, 219-224 (2005).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.